Effect of hyperbaric oxygen therapy on cerebral vasospasm: A vascular morphometric study in an experimental subarachnoid hemorrhage model

International Journal of Neuroscience

Volumn 124, Issue 8, 2014, Pages 593-600

  Çelik, Özgür ^a   Bay, Hüsniye Hacioǧlu ^a   Arslanhan, Ayça ^a   Oroǧlu, Bengüsu ^b   Bozkurt, Süheyla Uyar ^a   Şehirli, Ümit Süleyman ^a   Ziyal, Mustafa Ibrahim ^a  

^a MARMARA UNIVERSITY   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Cerebral vasospasm; Hyperbaric oxygen; Subarachnoid hemorrhage; Vascular morphometry; Vasospasm index; Wall thickness

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIAL WALL THICKNESS; ARTICLE; ATMOSPHERE; ATTENUATION; BASILAR ARTERY; BRAIN PERFUSION; BRAIN VASOSPASM; CONTROLLED STUDY; HISTOPATHOLOGY; HYPERBARIC OXYGEN; KRUSKAL WALLIS TEST; MALE; MORPHOMETRICS; NONHUMAN; RABBIT MODEL; RANK SUM TEST; SHAM PROCEDURE; SUBARACHNOID HEMORRHAGE; THERAPY EFFECT; TREATMENT DURATION; ANIMAL; DISEASE MODEL; METABOLISM; PATHOLOGY; PROCEDURES; RABBIT; RANDOMIZATION; TREATMENT OUTCOME; VASOSPASM, INTRACRANIAL;

ANIMALS; DISEASE MODELS, ANIMAL; HYPERBARIC OXYGENATION; MALE; RABBITS; RANDOM ALLOCATION; SUBARACHNOID HEMORRHAGE; TREATMENT OUTCOME; VASOSPASM, INTRACRANIAL;

EID: 84903834402     PISSN: 00207454     EISSN: 15635279     Source Type: Journal    
DOI: 10.3109/00207454.2013.865619     Document Type: Article

References (51)

1. Roos YB, deHaan RJ, Beenen LF, et al. Complications and outcome in patients with aneurysmal subarachnoid haemorrhage: A prospective hospital based cohort study in the Netherlands. J Neurol Neurosurg Psychiatry 2000; 68: 337-41
2. Frontera JA, Fernandez A, Schmidt JM, et al. Defining vasospasm after subarachnoid hemorrhage: What is the most clinically relevant definition? Stroke 2009; 40: 1963-1968
3. Krakovsky M, Rogatsky G, Zarchin N, Mayevsky A. Effect of hyperbaric oxygen therapy on survival after global cerebral ischemia in rats. Surg Neurol 1998; 49: 412-6
4. Vila JF, Balcarce PE, Abiusi GR, et al. Improvement in motor and cognitive impairment after hyperbaric oxygen therapy in a selected group of patients with cerebrovascular disease: A prospective single-blind controlled trial. Undersea Hyperb Med 2005; 32: 341-9
5. Matchett GA, Martin RD, Zhang JH. Hyperbaric oxygen therapy and cerebral ischemia: Neuroprotectivemechanisms.Neurol Res 2009; 31: 114-21
6. Churchill S, Weaver LK, Deru K, et al. A prospective trial of hyperbaric oxygen for chronic sequelae after brain injury (HYBOBI). Undersea Hyperb Med 2013; 40: 165-93
7. Scḧabitz WR, Schade H, Heiland S, et al. Neuroprotection by hyperbaric oxygenation after experimental focal cerebral ischemia monitored by MRI. Stroke 2004; 35: 1175-1179
8. Ugriumov VM, Elinskii MP, Rafikov AM, Kesaev SA. Hyperbaric oxygenation in the complex treatment of patients with aneurysms of the cerebral vessels. Zh Vopr Neirokhir Im NN Burdenko 1980; Jul-Aug: 49-54
9. Kitaoka K, Nakagawa Y, Abe H, et al. Hyperbaric oxygenation for the mental conditions following surgery of aneurysm of the anterior communicating artery. Hokkaido Igaku Zasshi 1983; 58: 154-61
10. Isakov I, Pravdenkova SV, Shchelkovskii VN. Hyperbaric oxygenation in ruptured cerebral aneurysms during the postoperative period. Zh Vopr Neirokhir Im NN Burdenko 1985; Jul-Aug: 17-21
11. Kawamura S, Ohta H, Yasui N, et al. Effects of hyperbaric oxygenation in patients with subarachnoid hemorrhage. J Hyperb Med 1988; 3: 243-56
12. Levina OA, Romasenko MV, Krylov V. Therapeutic effects of hyperbaric oxygenation (HBO) on acute cerebral ischemia in patients after intracranial aneurysms clipping. Eur J Underw Hyperb Med 2002; 3: 83
13. Ohta H, Suzuki E, Hinuma Y, et al. Effects of hyperoxia, glycerol and ventricular drainage on ICP and CBF in patients with increased ICP due to CSF circulatory-Absorbance disturbance. No To Shinkei 1987; 39: 273-9
14. Kohshi K, Yokota A, Konda N, et al. Intracranial pressure responses during hyperbaric oxygen therapy. Neurol Med Chir (Tokyo) 1991; 31: 575-81
15. Kohshi K, Yokota A, Konda N, et al.Hyperbaric oxygen therapy adjunctive to mild hypertensive hypervolemia for symptomatic vasospasm. Neurol Med Chir (Tokyo) 1993; 33: 92-9
16. Ostrowski RP, Colohan AR, Zhang JH. Mechanisms of hyperbaric oxygen-induced neuroprotection in a rat model of subarachnoid hemorrhage. J Cereb Blood Flow Metab 2005; 25: 554-71
17. Ostrowski RP, Tang J, Zhang JH.Hyperbaric oxygen suppresses NADPH oxidase in a rat subarachnoid hemorrhage model. Stroke 2006; 37: 1314-1318
18. Ostrowski RP, Colohan AR, Zhang JH. Neuroprotective effect of hyperbaric oxygen in a rat model of subarachnoid hemorrhage. Acta Neurochir Suppl 2006; 96: 188-93
19. Kocaǒgullar Y, Usẗun ME, Avci E, et al. The role of hyperbaric oxygen in the management of subarachnoid hemorrhage. Intensive Care Med 2004; 30: 141-6
20. Tang XP, Tan M, Zhang T, et al. Effects of early hyperbaric oxygen therapy on clinical outcome in postoperative patients with intracranial aneurysm. Undersea Hyperb Med 2011; 38: 493-501
21. Walid SM, Zaytseva NV. Quadruple H therapy for vasospasm. Ann Indian Acad Neurol 2009; 12: 22-4
22. Ostrowski RP, Zhang JH. Hyperbaric Oxygen for Cerebral Vasospasm and Brain Injury Following Subarachnoid Hemorrhage. Transl Stroke Res 2011; 2: 316-27
23. Griessenauer CJ, Shoja MM, Loukas M, Tubbs RS. The value of hyperbaric oxygen therapy in postoperative care of subarachnoid hemorrhage. Med Gas Res. 2012; 2: 29
24. Lan C, Das D, Wloskowicz A, Vollrath B. Endothelin-1 modulates hemoglobin-mediated signaling in cerebrovascular smooth muscle via RhoA/Rho kinase and protein kinase C. Am J Physiol Heart Circ Physiol 2004; 286: H165-73
25. Miao L, Dai Y, Zhang J. Mechanism of RhoA/Rho kinase activation in endothelin-1-induced contraction in rabbit basilar artery. Am J Physiol Heart Circ Physiol 2002; 283: H983-9
26. Zhou C, Li Y, Nanda A, Zhang JH. HBO suppresses Nogo-A, Ng-R, or RhoA expression in the cerebral cortex after global ischemia. Biochem Biophys Res Commun 2003; 309: 368-76
27. Harrod CG, Bendok BR, Batjer HH. Prediction of cerebral vasospasm in patients presenting with aneurysmal subarachnoid hemorrhage: A review. Neurosurgery 2005; 56: 633-54
28. Sercombe R, Dinh YR, Gomis P. Cerebrovascular inflammation following subarachnoid hemorrhage. Jpn J Pharmacol 2002; 88: 227-49
29. Chaichana KL, Pradilla G, Huang J, Tamargo RJ. Role of inflammation (leukocyte-endothelial cell interactions) in vasospasm after subarachnoid hemorrhage. World Neurosurg 2010; 73: 22-41
30. Mocco J, Mack WJ, Kim GH, et al. Rise in serum soluble intercellular adhesion molecule-1 levels with vasospasm following aneurysmal subarachnoid hemorrhage. J Neurosurg 2002; 97: 537-41
31. Mack WJ, Mocco J, Hoh DJ, et al. Outcome prediction with serum intercellular adhesion molecule-1 levels after aneurysmal subarachnoid hemorrhage. J Neurosurg 2002; 96: 71-5
32. PolinRS, BavbekM, ShaffreyME, et al. Detection of soluble Eselectin, ICAM-1, VCAM-1, and L-selectin in the cerebrospinal fluid of patients after subarachnoid hemorrhage. J Neurosurg 1998; 89: 559-67
33. Aihara Y, KasuyaH, Onda H, et al.Quantitative analysis of gene expressions related to inflammation in canine spastic artery after subarachnoid hemorrhage. Stroke 2001; 32: 212-7
34. Handa Y, Kubota T, KanekoM, et al. Expression of intercellular adhesionmolecule 1 (ICAM-1) on the cerebral artery following subarachnoid haemorrhage in rats. Acta Neurochir (Wien) 1995; 132: 92-7
35. Sills Jr. AK, Clatterbuck RE, Thompson RC, et al. Endothelial cell expression of intercellular adhesion molecule 1 in experimental posthemorrhagic vasospasm. Neurosurgery 1997; 41: 453-61
36. Oshiro EM, Hoffman PA, Dietsch GN, et al. Inhibition of experimental vasospasm with anti-intercellular adhesion molecule-1 monoclonal antibody in rats. Stroke 1997; 28: 2031-2038
37. Bavbek M, Polin R, Kwan AL, et al. Monoclonal antibodies against ICAM-1 and CD18 attenuate cerebral vasospasm after experimental subarachnoid hemorrhage in rabbits. Stroke 1998; 29: 1930-1936
38. Buras JA, Stahl GL, Svoboda KK, Reenstra WR. Hyperbaric oxygen downregulates ICAM-1 expression induced by hypoxia and hypoglycemia: The role of NOS. Am J Physiol Cell Physiol 2000; 278: C292-302
39. Lasky LA. Selectins: Interpreters of cell-specific carbohydrate information during inflammation. Science 1992; 258: 964-9
40. Rosen SD. Cell surface lectins in the immune system. Semin Immunol 1993; 5: 237-47
41. Lin CL, Dumont AS, Calisaneller T, et al. Monoclonal antibody against E selectin attenuates subarachnoid hemorrhageinduced cerebral vasospasm. Surg Neurol 2005; 64: 201-6
42. Alex J, Laden G, Cale AR, et al. Pretreatment with hyperbaric oxygen and its effect on neuropsychometric dysfunction and systemic inflammatory response after cardiopulmonary bypass: A prospective randomized double-blind trial. J Thorac Cardiovasc Surg 2005; 130: 1623-30
43. Dumont AS, Dumont RJ, Chow MM, et al. Cerebral vasospasm after subarachnoid hemorrhage: Putative role of inflammation. Neurosurgery 2003; 53: 123-35
44. Osuka K, Suzuki Y, Watanabe Y, et al. Inducible cyclooxygenase expression in canine basilar artery after experimental subarachnoid hemorrhage. Stroke 1998; 29: 1219-22
45. Tran Dinh YR, Jomaa A, Callebert J, et al. Overexpression of cyclooxygenase-2 in rabbit basilar artery endothelial cells after subarachnoid hemorrhage. Neurosurgery 2001; 48: 626-35
46. Č elikö, Bilginer B, Korkmaz A, et al. Effects of intramuscular parecoxib administration on vasospasm in an experimental subarachnoid hemorrhagemodel. Int JNeurosci 2011; 121: 316-22
47. Yin W, Badr AE, Mychaskiw G, Zhang JH. Down regulation of COX-2 is involved in hyperbaric oxygen treatment in a rat transient focal cerebral ischemia model. Brain Res 2002; 926: 165-71
48. Zubkov AY, Ogihara K, Bernanke DH, et al. Apoptosis of endothelial cells in vessels affected by cerebral vasospasm. Surg Neurol 2000; 53: 260-6
49. Zhou C, YamaguchiM, Kusaka G, et al. Caspase inhibitors prevent endothelial apoptosis and cerebral vasospasm in dog model of experimental subarachnoid hemorrhage. J Cereb Blood Flow Metab 2004; 24: 419-31
50. Zhang Q, Chang Q, Cox RA, et al. Hyperbaric oxygen attenuates apoptosis and decreases inflammation in an ischemic wound model. J Invest Dermatol 2008; 128: 2102-12
51. Godman CA, Joshi R, Giardina C, et al. Hyperbaric oxygen treatment induces antioxidant gene expression. Ann NY Acad Sci 2010; 1197: 178-83